.png)
Image-Based Cellular Screening
At Apricell, we deliver advanced image-based screening solutions using high-content imaging, confocal microscopy, and 3D cell culture models. Our streamlined platform supports both 2D and 3D assays for multiparametric analysis of cell behavior and compound effects.
​
From custom assay development to full-service screening, we provide fast, flexible support tailored to your research goals. Whether you're validating targets or scaling drug discovery, Apricell helps turn complex biology into clear, actionable insights.
3D Cell Culture, Expertly Designed
Apricell specializes in advanced 3D cell culture models that offer greater in vivo relevance for drug screening. It is a rapidly evolving field with diverse models, media, and matrices. In collaboration with our expert cell biology team and partners, we help clients select or develop the right model for their research needs.
In addition to 3D assays, we also provide high-content screening with traditional monolayer cultures, allowing simultaneous analysis of multiple parameters at the same time. We ensure seamless application across both 3D and 2D formats with our flexible platform.
Insight-Powered Imaging
We at Apricell handle the challenges of High Content Screening (HCS) with a powerful, custom-built image analysis pipeline. Our software extracts precise quantitative metrics, including cell counts, morphology, and label colocalization, and produces clear, actionable reports in minutes.
Depending on the client's needs, we tailor each project accordingly. Providing small-scale proof-of-concept studies to demonstrate our expertise and ensure complete management of your screening campaigns is available upon request.
Data to Reports
Apricell specializes in turning complex, large-scale imaging datasets into clear, actionable insights that speed up drug discovery and development. With advanced 3D in vitro models, we can reveal disease mechanisms at unprecedented levels of detail with our proprietary high-content image analysis tools.
In addition to visualizing and quantifying cellular phenotypes in detail, our high-content imaging (HCI) capabilities support the evaluation of novel compounds and therapeutic strategies with greater precision. In order to support our clients' decision-making and drive innovation, we work closely with them to understand their research objectives.
Fluorescent images of the invaded non-resistant tumor cells from the tumoroid with the ECM matrix in response to different combinedand single treatment conditions.